PRF Technologies shares surge 43.61% after-hours as name change reflects expansion into diversified healthcare and AI-driven energy platforms.

PainReform surged 43.61% in after-hours trading following its announcement of a name change to PRF Technologies Ltd., reflecting a strategic shift into diversified healthcare and AI-driven energy platforms. The rebranding, approved by shareholders, underscores the company’s evolution beyond its single-product focus to a multi-platform business, including LayerBio’s ophthalmology treatments and DeepSolar’s AI-based solar analytics. These expansions into high-growth markets—such as non-opioid postoperative pain therapies, dropless ocular therapies, and renewable energy analytics—position PRF to leverage scalable opportunities, aligning with the stock’s sharp upward movement. CEO Dr. Ehud Geller emphasized the transformation, stating the company now addresses large markets through precision delivery and technology, reinforcing investor optimism.